US Stock MarketDetailed Quotes
CUE Cue Biopharma
- 0.679
- +0.225+49.61%
Close Sep 27 16:00 ET
- 0.710
- +0.031+4.50%
Post 20:01 ET
33.05MMarket Cap-700P/E (TTM)
0.710High0.450Low4.10MVolume0.455Open0.454Pre Close2.50MTurnover9.07%Turnover RatioLossP/E (Static)48.64MShares3.24952wk High1.53P/B30.76MFloat Cap0.45052wk Low--Dividend TTM45.28MShs Float31.690Historical High--Div YieldTTM57.21%Amplitude0.450Historical Low0.610Avg Price1Lot Size
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
Cue Biopharma Stock Forum
Cue Biopharma Presents Updated Data from Phase 1 Trial of CUE-101 in Recurrent/Metastatic HPV+ Head and Neck Cancer at the 2024 ASCO Annual Meeting
Cue Biopharma has presented updated data from its Phase 1 trial of CUE-101 at the 2024 ASCO Annual Meeting, revealing promising results for HPV+ head and neck cancer. The combination of CUE-101 and pembrolizumab in first-line (1L) treatment showed a 46% overall response rate (ORR) and a 96% 12-month overall survival (OS). ...
NEED IT TO BREAK OVER: $15.40
key indicator for MORE uptrend $15.55
confirmation uptrend - $16.16
mini breakout - $16.37
full breakout - $17.31
SEMI PARABOLIC - $18.25
stop loss - $14.31
support - $12.98. $Cue Biopharma (CUE.US)$
No comment yet